08 LC 33
2324
House
Bill 1090
By:
Representatives Stephens of the
164th,
Carter of the
159th,
Parham of the
141st,
and Parrish of the
156th
A
BILL TO BE ENTITLED
AN ACT
AN ACT
To
amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating
to controlled substances, so as to change certain provisions relating to
Schedule I, II, III, and IV controlled substances; to change certain provisions
relating to the definition of "dangerous drug"; to provide an effective date; to
repeal conflicting laws; and for other purposes.
BE
IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:
SECTION
1.
Chapter
13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled
substances, is amended in Code Section 16-13-25, relating to Schedule I
controlled substances, by adding new subparagraphs to paragraph (3) to read as
follows:
"(ZZ)
4-iodo-2,5-dimethoxyamphetamine;
(AAA)
4-chloro-2,5-dimethoxyamphetamine;"
SECTION
2.
Said
chapter is further amended in Code Section 16-13-25, relating to Schedule I
controlled substances, by revising paragraph (8) as follows:
"(8)
1-(3-Trifluoromethylphenyl)
1-(3-Trifluoromethylphenyl)
Piperazine (TFMPP);"
SECTION
3.
Said
chapter is further amended in Code Section 16-13-26, relating to Schedule II
controlled substances, by adding a new subparagraph to paragraph (3) to read as
follows:
"(G)
Lisdexamfetamine;"
SECTION
4.
Said
chapter is further amended in Code Section 16-13-27, relating to Schedule III
controlled substances, by deleting the period at the end of paragraph (10) and
replacing it with a semicolon and by adding a new paragraph to read as
follows:
"(11)
Embutramide."
SECTION
5.
Said
chapter is further amended in Code Section 16-13-28, relating to Schedule IV
controlled substances, by adding new paragraphs to subsection (a) to read as
follows:
"(1.5)
Armodafinil;"
"(11.5)
Eszopiclone;"
SECTION
6.
Said
chapter is further amended in Code Section 16-13-71, relating to the definition
of dangerous drug, by revising paragraphs (160.15) and (402.7) in subsection (b)
as follows:
"(160.15)
Cetirizine -
See exceptions;"
"(402.7)
Fluticasone
Propionate;"
SECTION
7.
Said
chapter is further amended in Code Section 16-13-71, relating to the definition
of dangerous drug, by adding new paragraphs to subsection (b) to read as
follows:
"(19.77)
Aliskiren;"
"(28.5)
Ambrisentan;"
"(44.6)
Ammonia, N-13;"
"(67.67)
Astenajavol;"
"(317.2)
Doripenem;"
"(330.3)
Eculizumab;"
"(506.9)
Ixabepilone;"
"(512.3)
Lanreotide;"
"(
512.67) Lapatinib;"
"(516.75)
Levocetirizine;"
"(540.3)
Maraviroc;"
"(595.5)
Methoxy polyethylene glycol-epoetin beta;"
"(638.45)
Nebivolol;"
"(644.3)
Nilotinib;"
"(831.03)
Raltegravir;"
"(836.3)
Retapamulin;"
"(845.95)
Rotigotine;"
"(851.045)
Sapropterin;"
"(
931.77) Temsirolimus;"
SECTION
8.
Said
chapter is further amended in Code Section 16-13-71, relating to the definition
of dangerous drug, by adding a new paragraph to subsection (c) to read as
follows:
"(6.5)
Cetirizine - when a single dosage unit is either 1mg per 1ml or less or 10mg or
less;"
SECTION
9.
This
Act shall become effective upon its approval by the Governor or upon its
becoming law without such approval.
SECTION
10.
All
laws and parts of laws in conflict with this Act are repealed.